Cavos

Genevation

This biotechnology company develops personalised mRNA cancer vaccines and therapeutics using artificial intelligence for patients requiring precision oncology treatments.

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

Medici Therapeutics

The company develops personalised mRNA cancer vaccines and T cell therapies for patients to treat tumours and combat age-related cellular decline.

Avenge Bio

This biotechnology firm develops cell-based immunotherapies for patients with solid tumours, specifically targeting metastatic peritoneal cancers like ovarian cancer.

CircNova

This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.

Ayuvant

The company develops RNA nanoparticle immunotherapies to treat cancer patients who do not respond to existing immune checkpoint inhibitors.

Kerna

This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.

Fauna Bio

This company develops an artificial intelligence platform to identify drug targets for pharmaceutical partners by analysing genetic data from disease-resistant animal species.